These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16687065)

  • 1. Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica?
    Okai AF; Muppidi S; Bagla R; Leist TP
    Neurol Res; 2006 Apr; 28(3):354-9. PubMed ID: 16687065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis.
    de Seze J; Lebrun C; Stojkovic T; Ferriby D; Chatel M; Vermersch P
    Mult Scler; 2003 Oct; 9(5):521-5. PubMed ID: 14582780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive necrotic myelopathy: clinical course in 9 patients.
    Katz JD; Ropper AH
    Arch Neurol; 2000 Mar; 57(3):355-61. PubMed ID: 10714661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
    Papais Alvarenga RM; Araújo ACRAE; Nascimento ACB; Araujo NEC; Meneguette NS; Neri VC; Papais Alvarenga M; Filho HA; Barros PO; Bento CA; Schmidt SL; Vasconcelos CCF; Alvarenga MP
    Mult Scler Relat Disord; 2020 Jul; 42():102082. PubMed ID: 32361664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis.
    Etemadifar M; Mollabashi M; Chitsaz A; Behnamfar O; Bahrami E; Minagar A; Maghzi AH
    Clin Neurol Neurosurg; 2012 Jan; 114(1):17-20. PubMed ID: 22014378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Devic's neuromyelitis optica. Presentation of 2 new cases and review of the bibliography].
    Carod Artal FJ; Brenner C; Melo M; del Negro MC; Pereira R
    Neurologia; 2000; 15(7):307-12. PubMed ID: 11075580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical course of neuromyelitis optica (Devic's syndrome).
    Wingerchuk DM; Hogancamp WF; O'Brien PC; Weinshenker BG
    Neurology; 1999 Sep; 53(5):1107-14. PubMed ID: 10496275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromyelitis optica.
    Wingerchuk DM
    Int MS J; 2006 May; 13(2):42-50. PubMed ID: 16635421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Devic's neuromyelitis optica: a critical review.
    Lana-Peixoto MA
    Arq Neuropsiquiatr; 2008 Mar; 66(1):120-38. PubMed ID: 18392436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].
    Bi CF; Qian HR; Peng LJ; Mao LL; Huang X; Xia DY; Lei X; Qi XK
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):460-5. PubMed ID: 27256609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica spectrum disorders (NMO-SD) in a Sub-Saharan Africa country: A preliminary study of sixteen Senegalese cases.
    Gaye NM; Fall M; Diop AM; Dadah SML; Ka M; Cissé O; Diagne NS; Diop-Sène MS; Sow AD; Basse-Faye AM; Sarr MM; Touré K; Seck LB; Ndiaye M; Diop AG
    Mult Scler Relat Disord; 2019 Jan; 27():179-183. PubMed ID: 30388487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune thyroiditis associated with neuromyelitis optica (NMO).
    Sudulagunta SR; Sodalagunta MB; Khorram H; Sepehrar M; Gonivada J; Noroozpour Z; Prasad N
    Ger Med Sci; 2015; 13():Doc22. PubMed ID: 26633965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain abnormalities in neuromyelitis optica.
    Pittock SJ; Lennon VA; Krecke K; Wingerchuk DM; Lucchinetti CF; Weinshenker BG
    Arch Neurol; 2006 Mar; 63(3):390-6. PubMed ID: 16533966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.
    Jacob A; McKeon A; Nakashima I; Sato DK; Elsone L; Fujihara K; de Seze J
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):922-30. PubMed ID: 23142960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revised diagnostic criteria for neuromyelitis optica.
    Wingerchuk DM; Lennon VA; Pittock SJ; Lucchinetti CF; Weinshenker BG
    Neurology; 2006 May; 66(10):1485-9. PubMed ID: 16717206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive Myelopathy in a Patient with Pediatric Onset Neuromyelitis Optica Spectrum Disorder: A Case Report and a Mini Review.
    Moghadasi AN
    Acta Neurol Taiwan; 2020 Mar; 29(1)():1-4. PubMed ID: 32285427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.